Sign in
XSNX Stock Price, Chart, Stats & News
NovAccess Global Inc.
Save
NovAccess Global Inc. (XSNX) does not currently pay a dividend.
12,330
Market cap
–
Current P/E
–
Forward P/E
XSNX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
Similar securities
Based on sector and market capitalization
Report issue